Global Hemp Group Inc. — Investor Relations & Filings
Global Hemp Group Inc. focuses on two key segments: Industrial Hemp and Biopharma. The Industrial Hemp division develops innovative, green, and sustainable solutions utilizing the whole hemp plant for environmental applications, including carbon-negative construction materials, sustainable bio-energy sources, bio-composites, textiles, and nonwovens. This strategy is executed through the Hemp Agro-Industrial Zone (HAIZ) concept, which integrates raw material supply with industrial processing. The company also maintains an R&D division dedicated to developing patented IP for hemp-based eco-friendly building materials. The Biopharma division centers on acquiring exclusive licensing of advanced Intellectual Property, notably holding exclusive perpetual licenses to Apollon Formularies' proprietary technology and patents for developing cancer treatments from natural biologics (such as medical cannabis and functional mushrooms) using an AI-based drug discovery platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2024-01-29 | English | |
| News release - English.pdf | 2024-01-17 | English | |
| News release - English.pdf | 2024-01-15 | English | |
| News release - English.pdf | 2024-01-08 | English | |
| News release - English.pdf | 2024-01-08 | English | |
| News release - English.pdf | 2023-10-16 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
5 filings
| |||||
| 29555896 | News release - English.pdf | 2024-01-29 | English | ||
| 13713812 | News release - English.pdf | 2024-01-17 | English | ||
| 29515045 | News release - English.pdf | 2024-01-15 | English | ||
| 29512024 | News release - English.pdf | 2024-01-08 | English | ||
| 29511996 | News release - English.pdf | 2024-01-08 | English | ||
|
2023
10 filings
| |||||
| 13697905 | News release - English.pdf | 2023-10-16 | English | ||
| 13697904 | Offering document - English.pdf | 2023-10-16 | English | ||
| 29335716 | News release - English.pdf | 2023-10-11 | English | ||
| 13694923 | Other securityholders documents - English.pdf | 2023-09-26 | English | ||
| 13694931 | Material change report - English.pdf | 2023-09-26 | English | ||
| 13694939 | News release - English.pdf | 2023-09-26 | English | ||
| 29034486 | News release - English.pdf | 2023-08-18 | English | ||
| 28711372 | Form of proxy - English.pdf | 2023-06-22 | English | ||
| 28711360 | Other.pdf | 2023-06-22 | English | ||
| 28711350 | Management information circular - English.pdf | 2023-06-22 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Global Hemp Group Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46553/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46553 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46553 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46553 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46553}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Global Hemp Group Inc. (id: 46553)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.